Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463796 · ClinicalTrials.gov registry record
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
A clinical trial of Lung Cancer and Barrett Esophagus, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT05463796 is a study of Lung Cancer and Barrett Esophagus that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 5,000 participants, above the 924-participant average among 409 other Lung Cancer trials with a reported enrollment target (441% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05463796, a study of Lung Cancer and Barrett Esophagus, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or has been diagnosed with an early phase of a cancer or a family member who has a family member with a precursor condition for cancer. * The objective of this study is to identify exposures as well as clinical, molecular, and pathological changes that can be used to predict early development of cancer, malignant transformation, and risks of progression to symptomatic cancer that can ultimately be fatal. * The ultimate goal is to identify novel markers of early detection and risk stratification to drive potential therapeutic approaches to intercept progression to cancer.
Conditions Studied
Interventions
- OTHER Samples
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2023-04-25 |
| Est. Completion | 2032-03-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05463796
The ClinicalTrials.gov registry entry for NCT05463796 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 924-participant average among 409 other Lung Cancer trials with a reported enrollment target (441% higher). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Samples is the first listed.
NCT05463796 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05463796 about?
NCT05463796 is a clinical study titled "InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer". This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or has been diagnosed with an early phase of a cancer or a family member who has a family member with a precursor condition for cancer. * The ...
What is the current status of trial NCT05463796?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-04-25. Estimated completion is 2032-03-25.
What conditions does trial NCT05463796 study?
This clinical trial studies the following conditions: Lung Cancer, Barrett Esophagus, Cancer Risk, Childhood Cancer Survivors, Cancer Predisposition Syndrome.
What interventions are being tested in trial NCT05463796?
The interventions under investigation include: Samples (OTHER).
Who is sponsoring clinical trial NCT05463796?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05463796 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.